Skip to main content
. 2019 Sep 3;21(5):e13158. doi: 10.1111/tid.13158

Table 2.

Type of CARV episodes and later‐occurring IFD according to CARV type and respiratory location

  EvRh RSV Influ HPiV hMPV AdV HCoV HBoV
Number of Episodes, n (%)a 238 (40) 136 (23) 118 (20) 97 (16) 60 (10) 12 (2) 36 (6) 17 (3)
Overall IFD, n (%)a 10 (4) 7 (5) 5 (4) 5 (5) 4 (7) 1 (8) 0 0
CARV URTD, n (%)a 170 (72) 79 (58) 77 (65) 61 (63) 34 (57) 4 (31) 26 (72) 12 (71)
IFD after URTD, n (%)a 2 (1) 1 (1) 0 0 1 (3) 0 0 0
CARV LRTD, n (%)a 68 (28) 57 (42) 41 (35) 36 (37) 26 (43) 8 (66) 10 (28) 5 (29)
IFD after LRTD, n (%)a 8 (12) 6 (11) 5 (12) 5 (14) 3 (11) 1 (13) 0 0

Abbreviation: ADV, adenovirus; AdV, adenovirus; CARV, community‐acquired respiratory virus; EvRh, Enterovirus/rhinovirus; HCoV, human coronavirus; hMPV, human metapneumovirus; HPiV, human parainfluenza virus; IFD, invasive pulmonary fungal disease; Influ, human influenza virus; LRTD, lower respiratory tract disease; RSV, respiratory syncytial virus; URTD, upper respiratory tract disease.

a

The sum of the episodes does not match the overall number of episodes (n = 597) since multiple CARVs were detected in the same respiratory sample in 116 (19%) out of 597 CARV episodes. IFD after CARV co‐infection was 8% (9 out of 116)

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.